Updates
Intimation of Opening of Trading Window We refer to our earlier communication dated 26th June, 2017 regarding closure of trading window (for the purpose of financial results for the quarter ended 30th June, 2017) starting from 29th June, 2017 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter ended on 30th June, 2017 are communicated to the Stock Exchanges.... Press Release / Media Release
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith press release and analyst presentation on Q1FY18 earnings and business updates and the same will be uploaded on the website of the Company. Kindly take note of the same. Financial Results For 30/06/2017
In continuation of our letter dated 27th July, 2017 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we are enclosing the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2017, duly approved by the Board of Directors of the Company, at its meeting held today, i.e. 11th... Outcome of Board Meeting
In continuation of our letter dated 27th July, 2017 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we are enclosing the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2017, duly approved by the Board of Directors of the Company, at its meeting held today, i.e. 11th... Outcome of Board Meeting
In continuation of our letter dated 27th July, 2017 and pursuant to Regulation 30 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we are enclosing the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30th June, 2017, duly approved by the Board of Directors of the Company, at its meeting held today, i.e. 11th... Notice Of The 43Rd Annual General Meeting (AGM) And Annual Report For FY 2016-2017
Please find enclosed herewith the Notice of the 43rd Annual General Meeting scheduled to be held on Friday, 8th September, 2017 at 10.30 a.m. at Nehru Centre Auditorium, Dr. Annie Besant Road, Worli, Mumbai 400 018 alongwith the Annual Report of the Company for the financial year 2016-2017. Intimation Of Conference Call On Q1FY18 Results
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q1FY18 financial results and business updates will be held on Friday, 11th August, 2017 at 5.00 P.M. Please find attached herewith the conference call details. Kindly take note of the same. Notice Of Meeting Of Board Of Directors Of Alkem Laboratories Limited ('Company')
Notice is hereby given to the Stock Exchanges under Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 11th August, 2017, inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended 30th June, 2017. Kindly take note of the same. Press Release
This is to inform you that US FDA had conducted an inspection at the Company's Bioequivalence facility located at Taloja, India from 10th July, 2017 to 14th July, 2017. At the end of the inspection, no Form 483 was issued. Kindly take note of the same. Statement Of Investor Grievances For The Quarter Ended 30Th June, 2017
In terms of Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Statement of Investor Grievances for the quarter ended 30th June, 2017. Kindly take the same on record.